Which drugs are most likely to be approved in Mixed Pain (Nociceptive Pain/Neuropathic Pain)?

Mixed Pain (Nociceptive Pain/Neuropathic Pain) disease is an indication for drug development with over 270 pipeline drugs currently active according to GlobalData.

UC Berkeley’s Groundbreaking Study Exploring Psilocybin’s Effects on Perception | Psychedelic Invest

The UC Berkeley Center for the Science of Psychedelics has embarked on an unprecedented study to explore why psilocybin, a psychoactive compound found in certain

June 14, 2024

One in Six Adults With Asthma Didn’t Adhere to Meds Due to Cost

Despite a declining trend, the number of adults in the U.S. who say they did not adhere to their asthma treatment because of costs remains

December 10, 2024

METRNL protein identified as key player in cancer progression

A protein called Meteorin-like (METRNL) in the tumor microenvironment saps energy from T cells, thereby severely limiting their ability to fight cancer, according to new

August 7, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.